C-Qur mesh made by Atrium is used primarily in hernia repair surgeries to support weakened tissue and to prevent recurring hernias. C-Qur mesh is also used to support tissue in traumatic wounds, surgical wounds, and chest wall reconstruction. In 2012, the Food and Drug Administration (FDA) issued a warning letter to Atrium regarding improper sterilization and failing to investigate other complaints. In 2013, the FDA issued a recall on all shapes and sizes of C-Qur mesh, C-Qur Tacshield mesh, C-Qur V-Patch mesh and C-Qur Edge mesh. The most common complications with Atrium’s C-Qur mesh are additional surgeries to treat hernia recurrence, additional surgeries to treat a mesh-related failure or injury, adhesions, bacterial infections, mesh migration, obstructions, pain and swelling.